These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 844192)

  • 1. The clearance of lipoprotein X in vitro, and effect of phospholipase A on serum lipoprotein X.
    Rubies-Prat J; Ras MR; Frison JC; Masdeu S; Bacardi R
    Clin Chim Acta; 1977 Feb; 75(1):117-21. PubMed ID: 844192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin on lecithin: cholesterol acyltransferase and lipids in cholestasis.
    Rubiés-Prat J; Ras MR; Frisón JC; Miquel C; Masdeu S; Bacardi R
    Digestion; 1976; 14(3):250-5. PubMed ID: 955331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of heparin on serum lipoprotein-X.
    Ras MR; Frison JC; Rubies-Prat J; Masdeu S; Bacardi R
    Clin Chim Acta; 1975 May; 61(1):91-3. PubMed ID: 168006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CONVERSION OF LIPOPROTEIN-BOUND LECITHIN TO LYSOLECITHIN INDUCED BY SNAKE-VENOM PHOSPHOLIPASE A.
    KLIBANSKY C; HENIG S; SHILOAH J; DEVRIES A
    Biochim Biophys Acta; 1963 Oct; 70():591-3. PubMed ID: 14085944
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence of agar gel electrophoresis changes of lipoprotein-X after phospholipase A and deoxycholic acid.
    Frisón JC; Ras MR; Rubiés-Prat J; Masdeu S; Schwartz S
    Digestion; 1977; 16(1-2):199-202. PubMed ID: 210069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid compositions of plasma major lipoproteins and lipoprotein lipase activity in hypolipidemic and hyperlipidemic siblings with familial LCAT deficiency.
    Naito C; Teramoto T; Kato H; Watanabe T; Yamanaka T; Iwamoto A
    Scand J Clin Lab Invest Suppl; 1978; 150():168-76. PubMed ID: 746345
    [No Abstract]   [Full Text] [Related]  

  • 8. Residual phospholipase A activity in lysolecithin prepared by the action of snake venom on ovolecithin.
    MARPLES EA; THOMPSON RH
    Biochim Biophys Acta; 1958 Oct; 30(1):187-8. PubMed ID: 13584414
    [No Abstract]   [Full Text] [Related]  

  • 9. USE OF TRYPSIN TO ELIMINATE RESIDUAL SNAKE-VENOM PHOSPHOLIPASE A ACTIVITY IN LYSOLECITHIN PREPARED FROM OVOLECITHIN.
    DOIZAKI WM; ZIEVE L
    Biochim Biophys Acta; 1963 Dec; 70():703-4. PubMed ID: 14102759
    [No Abstract]   [Full Text] [Related]  

  • 10. The cofactor effects of serum lipoproteins on lipoprotein lipase activity and its inhibition by heparin and protamine sulfate.
    Posner I; Morrison AD
    Acta Cient Venez; 1979; 30(2):152-61. PubMed ID: 543379
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in the concentration of lipoprotein-X during incubation of postheparin plasma from patients with familial lecithin: cholesterol acyltransferase (LCAT) deficiency.
    Ritland S; Stokke KT; Gjone E
    Clin Chim Acta; 1976 Feb; 67(1):63-9. PubMed ID: 815065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of snake venom, phospholipase A and trypsin on purified myelin in vitro.
    Banik NL; Gohil K; Davison AN
    Biochem J; 1976 Nov; 159(2):273-7. PubMed ID: 187172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentration of lipoprotein-X (LP-X) in experimental bile duct obstruction.
    Ritland S; Bergan A
    Scand J Gastroenterol; 1975; 10(1):17-24. PubMed ID: 1124340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of enzymatic conversion of lysolecithin to lecithin in normal human plasma.
    Subbaiah PV; Bagdade JD
    Life Sci; 1978 Jun; 22(22):1971-7. PubMed ID: 672439
    [No Abstract]   [Full Text] [Related]  

  • 16. ACTION OF BOVINE AND HUMAN PANCREATIC PHOSPHOLIPASE A ON LIPOPROTEIN-BOUND PHOSPHOLIPIDS.
    CONDREA E; KLIBANSKY C; KERET R; DEVRIES A
    Nature; 1963 Dec; 200():1096-7. PubMed ID: 14098436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC; Berthold S; Schlumpf E; Keller H; Riva G
    Schweiz Med Wochenschr; 1975 Jul; 105(27):863-72. PubMed ID: 2969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density lipoproteins in cholestasis.
    Blomhoff JP
    Scand J Gastroenterol; 1974; 9(6):591-6. PubMed ID: 4370571
    [No Abstract]   [Full Text] [Related]  

  • 19. The fusion of abnormal plasma lipoprotein (LP-X) and the erythrocyte membrane in patients with cholestasis studied by electronmicroscopy.
    Verkleij AJ; Nauta IL; Werre JM; Mandersloot JG; Reinders B; Ververgaert PH; de Gier J
    Biochim Biophys Acta; 1976 Jun; 436(2):366-76. PubMed ID: 1276221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-heparin serum lecithinase in man and its positional specificity.
    Vogel WC; Bierman EL
    J Lipid Res; 1967 Jan; 8(1):46-53. PubMed ID: 14564704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.